Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jean Marie Connors, M.D.

Co-Author

This page shows the publications co-authored by Jean Connors and Hanny Al-Samkari.
Connection Strength

7.496
  1. Impact of ALK Rearrangement on Venous and Arterial Thrombotic Risk in NSCLC. J Thorac Oncol. 2020 09; 15(9):1497-1506.
    View in: PubMed
    Score: 0.873
  2. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy. Hematology Am Soc Hematol Educ Program. 2019 12 06; 2019(1):71-79.
    View in: PubMed
    Score: 0.848
  3. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy. Blood Adv. 2019 11 26; 3(22):3770-3779.
    View in: PubMed
    Score: 0.846
  4. Antifibrinolytic Agents for Hemoptysis Management in Adults With Cystic Fibrosis. Chest. 2019 06; 155(6):1226-1233.
    View in: PubMed
    Score: 0.802
  5. The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis. Cancers (Basel). 2018 Aug 15; 10(8).
    View in: PubMed
    Score: 0.774
  6. Ofatumumab for acute treatment and prophylaxis of a patient with multiple relapses of acquired thrombotic thrombocytopenic purpura. J Thromb Thrombolysis. 2018 Jul; 46(1):81-83.
    View in: PubMed
    Score: 0.768
  7. Dual anticoagulation with fondaparinux and dabigatran for treatment of cancer-associated hypercoagulability. Am J Hematol. 2018 06; 93(6):E156-E158.
    View in: PubMed
    Score: 0.757
  8. Anticoagulation and Enzalutamide: Caution Over Convenience. J Oncol Pract. 2017 11; 13(11):728-729.
    View in: PubMed
    Score: 0.733
  9. A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies. Haematologica. 2021 04 01; 106(4):1148-1157.
    View in: PubMed
    Score: 0.232
  10. Cancer and thrombosis: new insights to an old problem. J Med Vasc. 2020 Nov; 45(6S):6S8-6S16.
    View in: PubMed
    Score: 0.226
  11. Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients. Cancers (Basel). 2020 Jul 19; 12(7).
    View in: PubMed
    Score: 0.221
  12. Thrombophilia evaluation in pulmonary embolism. Curr Opin Cardiol. 2019 11; 34(6):603-609.
    View in: PubMed
    Score: 0.211
  13. Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients. Vasc Health Risk Manag. 2019; 15:175-186.
    View in: PubMed
    Score: 0.205
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.